Delcath Systems, Inc. (NASDAQ:DCTH) Q1 2026 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Delcath Systems First Quarter 2026 Earnings Conference Call.
Delcath Systems Inc. (DCTH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Propel Bio Management Leen Kawas And Richard Kayne | 979,698 | $9,159,490 | +124% | 5.77% |
| 2. | Royce & Associates Chuck Royce | 195,000 | $1,809,600 | +26% | 0.02% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 191,630 | $1,778,328 | +688% | 0% |
| 4. | Renaissance Technologies Jim Simons | 155,300 | $1,441,184 | -58% | 0% |
| 5. | 100,000 | $928,000 | 0.37% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.04 | 5,533 | $50,018.32 | 77,018 | 2026-03-06 | Filing | |
| $8.96 | 11,200 | $100,309.44 | 342,034 | 2026-03-02 | Filing | |
| $8.89 | 4,386 | $38,991.54 | 14,936 | 2025-11-21 | Filing | |
| $8.53 | 11,500 | $98,049.00 | 330,834 | 2025-11-11 | Filing | |
| $3.72 | 26,882 | $100,001.04 | 1,069,710 | 2024-03-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.75 | 34,606 | $129,789.80 | 150,000 | 2012-01-06 | Filing | |
| $2.47 | 10,000 | $24,660.00 | 631,294 | 2011-12-23 | Filing | |
| $2.44 | 10,000 | $24,421.00 | 641,294 | 2011-12-22 | Filing | |
| $2.00 | 10,000 | $20,000.00 | 651,294 | 2011-12-21 | Filing | |
| $1.95 | 10,000 | $19,500.00 | 661,294 | 2011-12-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,300,389 | $30,627,610 | 12.31% | |
| 2. | 1,784,466 | $16,559,844 | 0% | |
| 3. | 1,329,288 | $12,335,793 | 0% | |
| 4. | 591,524 | $5,489,343 | 1.54% | |
| 5. | 261,126 | $2,423,249 | 0.04% |
News See All
Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2025 Earnings Call Transcript
Operator: It is now my pleasure to turn the conference over to Mr. David Hoffman, Delcath Systems, Inc. General Counsel. Thank you. You may begin. Please note this conference is being recorded.
Clear Street Raises Delcath Systems, Inc. (DCTH) Target to $29, Maintains Buy Rating
On January 9, Clear Street raised its price target on Delcath Systems, Inc. (NASDAQ:DCTH) to $29 from $28 while maintaining a Buy rating following the release of preliminary fourth-quarter results.
10 Best Long Term Healthcare Stocks to Buy
Investing in healthcare stocks offers a combination of defensive stability and long-term growth potential, supported by consistent demand for medical services, pharmaceuticals, and healthcare technologies...
Here's What Hit Delcath Systems (DCTH) in Q3
Riverwater Partners, an investment management company, released its “Micro Opportunities Strategy” Q3 2025 investor letter. A copy of the letter can be downloaded here.
10 Fast-Growing Small Cap Stocks to Buy According to Analysts
On October 1, Francis Gannon, Co-Chief Investment Officer and Managing Director at Royce Investment Partners, released a report analyzing small-cap performance during the third quarter of 2025.
Delcath Systems, Inc. (NASDAQ:DCTH) Q3 2025 Earnings Call Transcript
Delcath Systems, Inc. (NASDAQ:DCTH) Q3 2025 Earnings Call Transcript November 4, 2025Delcath Systems, Inc. reports earnings inline with expectations.
Invesco Backs Delcath Systems (DCTH) on Expansion Potential
Delcath Systems, Inc. (NASDAQ:DCTH) is among the fastest growing small cap stocks to buy. Invesco Ltd. has expanded its position in Delcath Systems, Inc.
11 Fastest Growing Small Cap Stocks to Buy
These days, everyone is obsessed with speed: fast fashion, fast food, fast internet.
H.C. Wainwright Remains Bullish on Delcath Systems (DCTH)
Delcath Systems, Inc. (NASDAQ:DCTH) is one of the best medical device stocks to buy according to analysts. On August 6, H.C.
Hedge Fund Resource Center